Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029463 (
osteosarcoma
)
16,637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sox9 is a transcription factor that is required for tissue development in mammals. In general, such transcription factors require co-regulators for precise temporal and spatial control of the activation and inactivation of the numerous genes necessary for precise development during embryogenesis. Here we identify a new Sox9 co-regulator: Using affinity chromatography with immobilized Sox9 protein, we identified
exportin 4
(
Exp4
) as an interacting protein of Sox9 in human cultured cells. Interaction between endogenous
Exp4
and Sox9 proteins was confirmed in the human
osteosarcoma
U2OS cells by immunoprecipitation experiments using anti-Sox9 antibody. siRNA depletion of
Exp4
enhanced transcription of Sox9 target genes in U2OS cells, but did not affect nuclear localization of Sox9. These results suggest that
Exp4
regulates Sox9 activity in the nucleus. Furthermore we found that the HMG box of Sox9 was responsible for binding to
Exp4
, and the HMG box was required for suppression of Sox9-mediated transcription. This contrasts with the known Sox9 co-regulators which bind to its transcriptional activation domain. Chromatin immunoprecipitation analyses revealed that
Exp4
prevents Sox9 binding to the enhancers of its target genes. These results demonstrate that
Exp4
acts as a Sox9 co-regulator that directly regulates binding of Sox9 to its target genes.
...
PMID:Exportin 4 interacts with Sox9 through the HMG Box and inhibits the DNA binding of Sox9. 2199 35